Annual EBITDA
-$114.05 M
-$76.70 M-205.34%
December 31, 2023
Summary
- As of February 8, 2025, BIOR annual EBITDA is -$114.05 million, with the most recent change of -$76.70 million (-205.34%) on December 31, 2023.
- During the last 3 years, BIOR annual EBITDA has fallen by -$7.87 million (-7.41%).
- BIOR annual EBITDA is now -205.34% below its all-time high of -$37.35 million, reached on December 31, 2022.
Performance
BIOR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$20.14 M
-$27.35 M-378.92%
September 30, 2024
Summary
- As of February 8, 2025, BIOR quarterly EBITDA is -$20.14 million, with the most recent change of -$27.35 million (-378.92%) on September 30, 2024.
- Over the past year, BIOR quarterly EBITDA has stayed the same.
- BIOR quarterly EBITDA is now -378.92% below its all-time high of $7.22 million, reached on June 30, 2024.
Performance
BIOR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$27.96 M
+$50.60 M+64.41%
September 30, 2024
Summary
- As of February 8, 2025, BIOR TTM EBITDA is -$27.96 million, with the most recent change of +$50.60 million (+64.41%) on September 30, 2024.
- Over the past year, BIOR TTM EBITDA has stayed the same.
- BIOR TTM EBITDA is now -38.46% below its all-time high of -$20.20 million, reached on March 1, 2019.
Performance
BIOR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BIOR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -205.3% | 0.0% | 0.0% |
| 3 y3 years | -7.4% | 0.0% | 0.0% |
| 5 y5 years | -4.9% | 0.0% | 0.0% |
BIOR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -205.3% | +30.7% | -378.9% | +74.9% | at high | +84.6% |
| 5 y | 5-year | -205.3% | +30.7% | -378.9% | +74.9% | at high | +84.6% |
| alltime | all time | -205.3% | +30.7% | -378.9% | +74.9% | -38.5% | +84.6% |
Biora Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.14 M(-378.9%) | -$27.96 M(-64.4%) |
| Jun 2024 | - | $7.22 M(-664.4%) | -$78.57 M(-22.0%) |
| Mar 2024 | - | -$1.28 M(-90.7%) | -$100.72 M(-11.7%) |
| Dec 2023 | -$114.05 M(+205.3%) | -$13.77 M(-80.5%) | -$114.05 M(+3.1%) |
| Sep 2023 | - | -$70.74 M(+373.7%) | -$110.65 M(+114.2%) |
| Jun 2023 | - | -$14.93 M(+2.2%) | -$51.66 M(+27.4%) |
| Mar 2023 | - | -$14.61 M(+41.0%) | -$40.56 M(+8.6%) |
| Dec 2022 | -$37.35 M(-77.3%) | -$10.37 M(-11.7%) | -$37.35 M(-65.2%) |
| Sep 2022 | - | -$11.74 M(+206.0%) | -$107.33 M(-16.7%) |
| Jun 2022 | - | -$3.84 M(-66.4%) | -$128.91 M(-20.6%) |
| Mar 2022 | - | -$11.41 M(-85.8%) | -$162.45 M(-10.8%) |
| Dec 2021 | -$164.57 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$80.35 M(+141.2%) | -$182.06 M(+43.2%) |
| Sep 2021 | - | -$33.32 M(-10.9%) | -$127.15 M(+2.3%) |
| Jun 2021 | - | -$37.38 M(+20.5%) | -$124.23 M(+9.6%) |
| Mar 2021 | - | -$31.02 M(+21.9%) | -$113.34 M(-14.9%) |
| Dec 2020 | -$106.18 M(-21.6%) | -$25.44 M(-16.3%) | -$133.15 M(-14.4%) |
| Sep 2020 | - | -$30.40 M(+14.8%) | -$155.48 M(-13.0%) |
| Jun 2020 | - | -$26.48 M(-47.9%) | -$178.75 M(+7.9%) |
| Mar 2020 | - | -$50.83 M(+6.4%) | -$165.64 M(+22.7%) |
| Dec 2019 | -$135.44 M(+24.6%) | -$47.77 M(-11.0%) | -$135.01 M(+54.8%) |
| Sep 2019 | - | -$53.66 M(+301.2%) | -$87.24 M(+159.8%) |
| Jun 2019 | - | -$13.38 M(-33.8%) | -$33.57 M(+66.2%) |
| Mar 2019 | - | -$20.20 M | -$20.20 M |
| Dec 2018 | -$108.69 M | - | - |
FAQ
- What is Biora Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Biora Therapeutics?
- What is Biora Therapeutics annual EBITDA year-on-year change?
- What is Biora Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Biora Therapeutics?
- What is Biora Therapeutics quarterly EBITDA year-on-year change?
- What is Biora Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Biora Therapeutics?
- What is Biora Therapeutics TTM EBITDA year-on-year change?
What is Biora Therapeutics annual EBITDA?
The current annual EBITDA of BIOR is -$114.05 M
What is the all time high annual EBITDA for Biora Therapeutics?
Biora Therapeutics all-time high annual EBITDA is -$37.35 M
What is Biora Therapeutics annual EBITDA year-on-year change?
Over the past year, BIOR annual EBITDA has changed by -$76.70 M (-205.34%)
What is Biora Therapeutics quarterly EBITDA?
The current quarterly EBITDA of BIOR is -$20.14 M
What is the all time high quarterly EBITDA for Biora Therapeutics?
Biora Therapeutics all-time high quarterly EBITDA is $7.22 M
What is Biora Therapeutics quarterly EBITDA year-on-year change?
Over the past year, BIOR quarterly EBITDA has changed by $0.00 (0.00%)
What is Biora Therapeutics TTM EBITDA?
The current TTM EBITDA of BIOR is -$27.96 M
What is the all time high TTM EBITDA for Biora Therapeutics?
Biora Therapeutics all-time high TTM EBITDA is -$20.20 M
What is Biora Therapeutics TTM EBITDA year-on-year change?
Over the past year, BIOR TTM EBITDA has changed by $0.00 (0.00%)